Skip to main content
Premium Trial:

Request an Annual Quote

Erik Christensen, Anders Lönneborg, Albert Luderer

Premium
Erik Christensen has been named managing director of DiaGenic effective Jan 1, 2007, the Norwegian diagnostics firm said this week.
 
Christensen currently manages the diagnostics division of Abbott Norway. DiaGenic’s current managing director and co-founder Anders Lönneborg will now serve as scientific director.
 

 
BioTrove has appointed Albert Luderer president and CEO.
 
Luderer, who will also become a BioTrove director, comes to the company from Light Sciences, where he was also president and CEO.
 
He has also been president and chief operating officer of BioMérieux and has held senior positions at Dianon Systems and Boehringer Mannheim.
 
Luderer has a BA from Drew University and an MS and PhD from Rutgers University.

Filed under

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.